MariÑas, Virginia B.
HRN: 25-61-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/04/2024
08/11/2024
IVT
500 Mg
Q6
TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes